awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37440061-03815D2D-8DB1-427A-A0EB-039402E37BF0
Q37440061-03815D2D-8DB1-427A-A0EB-039402E37BF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37440061-03815D2D-8DB1-427A-A0EB-039402E37BF0
Siglecs as targets for therapy in immune-cell-mediated disease.
P2860
Q37440061-03815D2D-8DB1-427A-A0EB-039402E37BF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37440061-03815D2D-8DB1-427A-A0EB-039402E37BF0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a5e8beb109dc2434bca84c49ab55455ec3d64b0
P2860
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group.